Cargando…
Case Report: AL Amyloidosis Severe Restrictive Cardiomyopathy Associated With Multiple Myeloma—Diagnostic Difficulties
BACKGROUND: Cardiac AL amyloidosis as a complication of multiple myeloma (MM) is a formidable life-threatening condition. The first-line therapy for both MM and systemic AL amyloidosis is proteasome inhibitors (PIs). Unfortunately, the use of PIs may lead to cardiovascular toxicity development, whic...
Autores principales: | Kirichenko, Yulia Y., Ilgisonis, Irina S., Nakhodnova, Elena S., Sokolova, Irina Y., Bochkarnikova, Olga V., Kardanova, Sabina A., Lyapidevskaya, Olga V., Privalova, Elena V., Ershov, Vladimir I., Belenkov, Yurii N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235537/ https://www.ncbi.nlm.nih.gov/pubmed/35770217 http://dx.doi.org/10.3389/fcvm.2022.862409 |
Ejemplares similares
-
Angiotensin-Converting Enzyme Inhibitor Therapy Effects in Patients With Heart Failure With Preserved and Mid-Range Ejection Fraction
por: Safonova, Julia, et al.
Publicado: (2021) -
Oligosecretory Myeloma With Amyloidosis and Alopecia
por: Bilal, Anum, et al.
Publicado: (2018) -
Evolution of Protein Functional Annotation: Text Mining Study
por: Ilgisonis, Ekaterina V., et al.
Publicado: (2022) -
Oral manifestations of systemic amyloidosis, an aid to diagnosis of multiple myeloma – report of two cases
por: Dissanayaka, D.W.V.N., et al.
Publicado: (2020) -
Radiation Risks of Leukemia, Lymphoma and Multiple Myeloma Incidence in the Mayak Cohort: 1948–2004
por: Kuznetsova, Irina S., et al.
Publicado: (2016)